1. Home
  2. DNOW vs NTLA Comparison

DNOW vs NTLA Comparison

Compare DNOW & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • NTLA
  • Stock Information
  • Founded
  • DNOW 1862
  • NTLA 2014
  • Country
  • DNOW United States
  • NTLA United States
  • Employees
  • DNOW N/A
  • NTLA N/A
  • Industry
  • DNOW Metal Fabrications
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • DNOW Industrials
  • NTLA Health Care
  • Exchange
  • DNOW Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • DNOW 1.6B
  • NTLA 1.4B
  • IPO Year
  • DNOW N/A
  • NTLA 2016
  • Fundamental
  • Price
  • DNOW $12.92
  • NTLA $12.18
  • Analyst Decision
  • DNOW Buy
  • NTLA Buy
  • Analyst Count
  • DNOW 2
  • NTLA 17
  • Target Price
  • DNOW $15.50
  • NTLA $56.63
  • AVG Volume (30 Days)
  • DNOW 767.8K
  • NTLA 2.4M
  • Earning Date
  • DNOW 02-13-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • DNOW N/A
  • NTLA N/A
  • EPS Growth
  • DNOW 59.45
  • NTLA N/A
  • EPS
  • DNOW 1.88
  • NTLA N/A
  • Revenue
  • DNOW $2,357,000,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • DNOW $3.53
  • NTLA $52.50
  • Revenue Next Year
  • DNOW $0.08
  • NTLA $0.42
  • P/E Ratio
  • DNOW $6.85
  • NTLA N/A
  • Revenue Growth
  • DNOW 1.90
  • NTLA N/A
  • 52 Week Low
  • DNOW $9.44
  • NTLA $11.79
  • 52 Week High
  • DNOW $15.65
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 31.22
  • NTLA 34.42
  • Support Level
  • DNOW $14.50
  • NTLA $11.79
  • Resistance Level
  • DNOW $15.15
  • NTLA $13.79
  • Average True Range (ATR)
  • DNOW 0.42
  • NTLA 0.85
  • MACD
  • DNOW -0.26
  • NTLA -0.14
  • Stochastic Oscillator
  • DNOW 0.49
  • NTLA 9.97

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies as well as companies operating in the decarbonization, energy transition and renewables end markets.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: